The benefits and limitations of needle protectors and needleless intravenous systems

Journal of Intravenous Nursing

Volumn 22, Issue 3, 1999, Pages 122-128

  Orenstein, Robert ^a  

^a Hunter Holmes McGuire Veterans Aff ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEVICE; DRUG MARKETING; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFUSION SYSTEM; NEEDLE; REVIEW; SAFETY; VASCULAR ACCESS;

CROSS INFECTION; HUMANS; INFECTION CONTROL; INFUSIONS, INTRAVENOUS; NEEDLESTICK INJURIES; NURSING STAFF; OCCUPATIONAL DISEASES; PROTECTIVE DEVICES;

EID: 0033505942     PISSN: 08965846     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. Linneman C, Cannon C, Deronde M, et al. The effect of educational programs, rigid sharps containers, and universal precautions on reported needlestick injuries in healthcare workers. Infect Control Hosp Epidemiol 1991;12:214-9.
2. Saghafi L, Raselli P, Francillon C, et al. Exposure to blood during various procedures: results of two surveys before and after implementation of universal precautions. Am J Infect Control 1992;20:53-7.
3. Wong ES, Stotka JL, Chinchilli VM, Williams DS, Stuart CG, Markowitz SM. Are universal precautions effective in reducing the number of occupational exposures among healthcare workers? JAMA 1991;265:1123-8.
4. Jagger J, Pearson RD. Universal precautions: still missing the point on needlesticks. Infect Control Hosp Epidemiol 1991;12:211-3.
5. Occupational Safety and Health Administration. 29 CFR part 1910.1030. Occupational exposure to blood-borne pathogens: Final rule. Federal Register 1991;56:64175-82.
6. McCormick RD, Meisch MG, Ircink FG, et al. Epidemiology of hospital sharps injuries: a 14 year prospective study in the pre-AIDS and AIDS eras. Am J Med 1991;91(S3B):301S-7S.
7. Jagger J, Hunt EL, Brand-Elnagger, et al. Rates of needlestick injury caused by various devices in a university hospital. N Engl J Med 1988;319:284-8.
8. Food and Drug Administration. FDA safety alert: Needlesticks and other risks from hypodermic needles on secondary IV administration sets: piggyback and intermittent IVs. Rockville, MD: U.S. Department of Health and Human Services, Public Health Service, FDA, April 16, 1992.
9. Kelly D. Trends in U.S. patents for needlestick prevention technology. Advances in Exposure Prevention 1996;2:7-8.
10. Whitby M, Stead P, Najman JM. Needlestick injury: impact of a recapping device and an associated education program. Infect Control Hosp Epidemiol 1991;12:220-5.
11. Duthle E. A case study examining the impact of implementing a needleless device for control of needlestick injuries. In: Implementing safer needle devices. Chicago: American Hospital Association, 1992.
12. Skolnick R, LaRocca J, Barba D, et al. Evaluation and implementation of a needleless intravenous system: making needlesticks a needleless problem. Am J Infect Control 1993;21:39-41.
13. Gartner K. Impact of a needleless intravenous system in a university hospital. Am J Infect Control 1992;20:75-9.
14. Owens-Schwab E, Fraser VJ. Needleless and needle protection devices: a second look at efficacy and selection. Infect Control Hosp Epidemiol 1993;14:657-60.
15. Rutkowski J, Peterson SL. A neeldeless intravenous system: an effective risk management strategy. Infect Control Hosp Epidemiol 1993;14:226-7.
16. National Center for Cost Containment, Department of Veterans Affairs, Washington, DC. Needlestick Prevention in the Department of Veterans Affairs, Monograph 1, August 1994.
17. Berry AJ. Are some types of needles more likely to transmit HIV to healthcare workers? Am J Infect Control 1993;21:216-8.
18. Culver J. Preventing transmission of blood-borne pathogens: a compelling argument for effective device selection strategies. Am J Infect Control 1997;25:430-3.
19. Centers for Disease Control and Prevention. Evaluation of safety devices for preventing percutaneous injuries among healthcare workers during phlebotomy procedures: Minneapolis-St. Paul, New York City and San Francisco, 1993-1995. MMWR 1997;46; 21-5.
20. Dale JC, Pruert SK, Maker MD. Accidental needlesticks in the phlebotomy service of the department of laboratory medicine and pathology at Mayo Clinic Rochester. Mayo Clin Proc 1998;73:611-5.
21. Mulherin S, Rickman LS, Jackson MM. Initial worker evaluation of a new safety syringe. Infect Control Hosp Epidemiol 1996;17: 593-4.
22. Ippolito G, DeCarli G, Puro V, et al. Device-specific risk of needlestick injury in Italian health care workers. JAMA 1994;272: 607-10.
23. Orenstein R, Reynolds L, Karabaic M, et al. Do protective devices prevent needlestick injuries among healthacre workers? Am J Infect Control 1995;23:344-51.
24. Ihrig M, Cookson ST, Campbell K, et al. Evaluation of the acceptability of a needleless vascular access system. Am J Infect Control 1997;25:434-8.
25. Mendelson MH, Short LJ, Schecter CB, et al. Study of a needleless intermittent intravascular access system for peripheral infusion: analysis of staff, patient and institutional outcomes. Infect Control Hosp Epidemiol 1998;19:401-6.
26. Lawrence LW, Delclos GL, Felknor SA, et al. The effectiveness of a needleless intravenous connection system: an assessment by injury rate and user safety. Infect Control Hosp Epidemiol 1997;18:175-82.
27. L'Ecuyer PB, Schwab EO, Iademarco E, et al. Randomized, prospective study of the impact of three needleless intravenous systems on needlestick injury rates. Infect Control Hosp Epidemiol 1996;17: 803-8.
28. Patel N, Tignor GH. Device-specific sharps injury and usage rates: an analysis by hospital department. Am J Infect Control 1997; 25:77-84.
29. National Center for Cost Containment, Department of Veterans Affairs, Washington, DC. Needlestick Prevention in the Department of Veterans Affairs, Monograph 2, November 1994.
30. National Center for Cost Containment, Department of Veterans Affairs, Washington, DC. Needlestick Prevention in the Department of Veterans Affairs, Monograph 3, February 1995.
31. National Center for Cost Containment, Department of Veterans Affairs, Washington, DC. Needlestick Prevention in the Department of Veterans Affairs, Follow-up survey results, November 1995.
32. National Center for Cost Containment, Department of Veterans Affairs, Washington, DC. Needlestick Prevention in the Department of Veterans Affairs, 1996 Follow-up survey results, May 1997.
33. Jagger JG. Reducing occupational exposures to bloodborne pathogens: where do we stand a decade later? Infect Control Hosp Epidemiol 1996;17:573-5.
34. Chodoff A, Pettis AM, Schoonmaker D, et al. Polymicrobial gram negative bacteremia associated with saline solution flush used with a needleless intravenous system. Am J Infect Control 1995;23: 357-63.
35. Do A, Ray B, Barnett B, et al. Evaluation of the role of needleless devices in bloodstream infections in home infusion therapy. Presented at the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, LA, September 17, 1996 (Abstract J61).
36. Danzig LE, Short LJ, Collins K, et al. Bloodstream infections associated with a needleless intravenous infusion system in patients receiving home infusion therapy. JAMA 1995;273:1862-4.
37. McDonald LC, Banerjee S, Jarvis WR. Central venous catheter-associated bloodstream infections in intensive care unit patients associated with needleless access devices (abstract). Infect Control Hosp Epidemiol 1997;18:P24.
38. Cookson ST, Ihrig M, O'Mara EM, et al. Increased bloodstream infection rates in surgical patients associated with variation from recommended use and care following implementation of a needleless device. Infect Control Hosp Epidemiol 1998;19:23-7.
39. Arduino MJ, Bland LA, Danzig LE, et al. Microbiologic evaluation of needleless and needle-access devices. Am J Infect Control 1997;26:377-80.
40. Maki DG, Stolz S, McCormick R, et al. Possible association of a commercial needleless system with central venous catheter-related bacteremia. Presented at the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy, October 4-7, 1994, Orlando, FL. Abstract J201.
41. Kellerman SE, Shay DK, Howard J, et al. Bloodstream infections in home infusion patients: the influence of race and needleless intravascular access devices. J Pediatr 1996;129:711-7.